期刊文献+

同型半胱氨酸与冠心病冠状动脉病变的相关性分析 被引量:3

CORRELATIONAL STUDY BETWEEN HOMOCYSTEININ AND CORONARY ATHEROSCLEROTIC DISEASE ON THE CORONARY ARTERY DISEASE
下载PDF
导出
摘要 目的:探讨同型半胱氨酸( Homocystein,Hcy)与冠心病患者冠状动脉病变程度的相关性。方法选取2013年1月∽2014年12月入住南方医科大学北滘医院的冠心病患者60例,所有入选患者均经冠状动脉造影并行 Genisi评分,检测外周血同型半胱酸表达;依据外周血同型半胱氨酸水平( Hcy≥10μmol /L定义为高 Hcy血症)分为冠心病组和冠心病并H同型半胱氨酸血症( Hyperhomocysteinemia,HHcy)组。分析两组患者外周血Hcy水平、冠状动脉病变程度等表达水平和相互间相关性。结果与冠心病患者相比,冠心病并 HHcy 血症患者 Genisi 评分和外周血 Hcy 水平高于冠心病患者( p<0.05);相关性分析显示所有入选患者外周血中Hcy水平与Genisi评分呈正相关(p<0.05)。结论 HHcy血症是冠心病的重要危险因素,与冠心病冠状动脉病变程度正相关。 Objective To investigate correlational study on the levels of homocysteinin with the severity of coronary artery in patients with coronary atherosclerotic disease.Methods 60 patients with coronary atherosclerotic disease were enrolled in from Janu-ary 2013 to December 2014 in Beijiao hospital affiliated Southern medical university .All patients received coronary artery angiograph and the levels of circulating homocysteinin were determined.According to the levels of circulating homocysteinin, 60 patients were de-vided into coronary atherosclerotic disease group and coronary atherosclerotic disease group with hyperhomocysteinemia ( HHcy) .The levels of homocysteinin and the severity of coronary artery in patients with coronary atherosclerotic disease and correlation between the two group were analyzed.Results Compared with coronary atherosclerotic disease patients,the levels of homocysteinemia and Genisi score were increased in patients with coronary atherosclerotic disease with HHcy (p〈0.05).Correlation analysis showed that the lev-els of homocystein is positively correlated with Genisi score (p〈0.05).Conclusion HHcy is a important risk for coronary athero-sclerotic disease and positively related with the severity of coronary artery in patients with coronary atherosclerotic disease .
作者 李剑平
出处 《现代医院》 2015年第8期18-20,共3页 Modern Hospitals
关键词 冠心病 同型半胱酸 Genisi评分 Coronary atherosclerotic disease Homocysteinin Genisi score
  • 相关文献

参考文献11

  • 1FAEH D, CHIOLERO A, PACCAUD F. Homocysteine as a risk factor for cardiovascular disease : should we (still) worry about it? [ J]. Swiss Med Wkly,2006,136:745 - 756.
  • 2BASZCZUK A, KOPCZYNSKI Z. Hyperhomocysteinemia in pa- tients with cardiovascular disease [ J ]. Postepy Hig Med Dosw, 2014,68:579.
  • 3Harald Mangge,Kathrin Becker,Dietmar Fuchs,Johanna M Gostner.Antioxidants,inflammation and cardiovascular disease[J].World Journal of Cardiology,2014,6(6):462-477. 被引量:29
  • 4VEERANNA V, ZALAWADIYA SK, NIRAJ A, et al. Homocys- teine and reclassification of cardiovascular disease risk [ J ]. J Am Coll Cardiol,2011,58 :1025 - 1033.
  • 5OKURA T, MIYOSHI K, IRITA J, et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males[ J]. Naturecom Sci Rep,2014,4:5663.
  • 6SHENOV V, MEHENDALE V, PRABHU K, et al. Correla- tion of serum homocysteine levels with the severity of coronary artery disease[ J ]. Ind J Clin Biochem, 2014,29 ( 3 ) : 339 - 344.
  • 7常娜,鲁广秀,张建磊.同型半胱氨酸与动脉粥样硬化型急性脑梗死患者颈动脉粥样硬化的相关性[J].实用医学杂志,2013,29(1):69-70. 被引量:52
  • 8陈文,林文海.无症状心功能不全2型糖尿病患者的同型半胱氨酸与N-末端脑钠肽前体水平的相关性[J].实用医学杂志,2013,29(11):1813-1814. 被引量:6
  • 9GANGULY P, ALAM SF. Role of homocysteine in the devel- opment of cardiovascular disease [ J ]. Nutr J, 2015,14:6.
  • 10STAMATELOPOULOS K S, LEKAKIS J P, TSEKE P, et al. Differential associations of renal function with coronary and peripheral atherosclerosis[ J]. International Journal of Cardiol- ogy,2009,135(2) :162 - 164.

二级参考文献18

  • 1王志宏,韩仲岩.急性缺血性脑血管病的TOAST亚型分类的临床意义[J].卒中与神经疾病,2007,14(3):190-191. 被引量:3
  • 2Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in normotensive men with well controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy[J]. Diabetes Care, 2001, 24(1):5-10.
  • 3Vasan R S, Beiser A, D'Agostino R B, et al. Plasma hornocysteine and risk for congestive heart failure in adults without prior myocardial infarction [J]. J Am Med Assoc, 2003,289(10):1251-1257.
  • 4Drzewoski J, Czuplyniak L, Chwatko G, et al. Total plasma homoeysteine and insulin levles in type 2 diabetie patients with seeondary failure to oral agents[J].Diabetes Care, 1999,22 (12) :2097-2099.
  • 5Shimabukuro M, Higa N, Oshiro Y, et al. Diagnostic Utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients [J]. Diabetes Obes Metabol, 2007,9(3) :323-329.
  • 6Herrmann M, Muller S, Kindermann J, et al. Plasma B vitamins and their relation to the severity of chronic heart failure [J]. Am J Clin Nutr, 2007,85 ( 1 ) : 117-123.
  • 7Brito D. Guidelines for the diagnosis and treatment of Chronic heart failure[J].Rev Port Cardiol, 2001,20(10) : 1527-1560.
  • 8Piccini J, Klein L, Gheorghiade M, et al. New insights into diastolic heart failure: role of diabetes mellitus [J]. Am J Med, 2004,116(Suppl 5A) : 64S-75S.
  • 9Stein B C, Levin R I. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemie heart disease [J]. Am Heart J, 1998,135(5 Pt 1):914-923.
  • 10Epshteyn V, Morrison K, Krishnaswamy P, et al. Utility of B- type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes [J]. Diabetes Care, 2003, 26(7) :2081-2087.

共引文献84

同被引文献30

  • 1ESTEGHAMATI A,HAFEZI-NEJAD N, ZANDIEH A, et al.Homocysteine and metabolic syndrome : from clustering to addi-tional utility in prediction of coronary heart disease [J].J Cardi-ol, 2014,64(4):290-296.
  • 2MA Y, LI L, GENG XB, et al. Correlation between hyperhomo-cysteinemia and outcomes of patients with acute myocardial in-farction [J].Am J Ther, 2014 Nov 17. [Epub ahead of print].
  • 3MALDONADO C, SONI CV, TODNEM ND, et al. Hyperhomo-cysteinemia and sudden cardiac death: potential arrhythmogenicmechanisms [J].Curr Vase Pharmacol, 2010,8(1): 64-74.
  • 4LIAO D, YANG X, WANG H, et al. Hyperhomocysteinemiaand high-density lipoprotein metabolism in cardiovascular dis-ease [J].Clin Chem Lab Med, 2007,45(12) : 1652-1659.
  • 5CHOI EY, YAN RT, FERNANDES VRS, et al. High-sensitivi-ty C-reactive protein as an independent predictor of progressivemyocardial functional deterioration : the multiethnic study ofatherosclerosis [J].J Am Heart, 2012,164(2) :251-258.
  • 6HONG MK, MINTZ GS, LEE CW, et al. Comparison of coro-nary plaque rupture between stable angina and acute myocardialinfarction : a three-vessel intravascular ultrasound study in 235patients [J].Circulation, 2004,110(8) :928-933.
  • 7BLAHA MJ, BUDOFF MJ, DEFILIPPIS AP, et al. Associationsbetween C-reactive protein, roronary calcium, and cardiovascu-lar events? : implications for the jupiter population from mesa, apopulation-based cohort study [J].Lancet, 2011,378 (9792):684-692.
  • 8WU Y, HUANG Y, HUY, et al. Hyperhomocysteinemia is anindependent risk factor in young patients with coronary arterydisease in southern China [ J].Herz, 2013,38(7) :779-784.
  • 9LENTZ SR. Does homocysteine promote atherosclerosis? [J].Arterioscler Thromb Vase Biol, 2001,21(9) : 1385-1386.
  • 10LAI WK, KAN MY. Homocysteine-induced endothelial dysfunc-tion [J].Ann Nutr Metab, 2015,67( 1) : 1-12.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部